Skip to content

The evaluation of a group therapy for patients with depressive symptoms after stroke - a pilot study

The evaluation of a group therapy for patients with depressive symptoms after stroke - a pilot study - Evaluation of a group therapy for depressive symptoms after stroke

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29896
Enrollment
12
Registered
2006-07-07
Start date
2006-04-10
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive symptoms

Interventions

The *Coping with depressive symptoms after stroke* course is a stroke adapted version of the *Coping with depression* course Dutch version by Cuijpers (1995). The course is expanded to give more att

Sponsors

iRv, Kenniscentrum voor Revalidatie en Handicap
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -he/she is receiving treatment in the HRC for stroke -he/she has sufficient cognitive abilities to follow the intervention, based on clinical judgement of a psychologist, with a Mini Mental State Examination score at least higher than 15 -he/she reports at least one emotional complaint on the CheckList for Cognitive and Emotional Consequences of Stroke (CLCE-24) -he/she is at least 18 years old

Exclusion criteria

Exclusion criteria: -insufficient understanding of the Dutch language -severe aphasia -insufficient physical abilities -serious vision or hearing problems -little or no insight into physical functioning, based on clinical judgement -co-morbid neurological disorders other than stroke -suffer or have suffered from a serious psychiatric disorder in the last five years for which he/she is treated for more than half a year by a psychiatrist -he/she did not give permission

Design outcomes

Primary

MeasureTime frame
The study parameters are mood, depressive symptoms and health related quality of life.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)